Evidence map›Paper›PMID 29881367›Full record

ArticleFrontiers in neurology2018

Frontotemporal Lobe Degeneration as Origin of Scans Without Evidence of Dopaminergic Deficit.

Manuel Menéndez-González, Tania Álvarez-Avellón, José M Salas-Pacheco, Benito de Celis-Alonso, Kathryn A Wyman-Chick, Oscar Arias-Carrión

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Unexpected (Journal of neurology · 2022
    Review
  3. Review
  4. Preserved ExtrastriatalMolecular imaging and biology · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Manuel Menéndez-GonzálezServicio de Neurología, Hospital Universitario Central de Asturias, Oviedo, Spain.
Tania Álvarez-AvellónDepartamento de Psicología, Universidad de Oviedo, Oviedo, Spain.
José M Salas-PachecoInstituto de Investigación Científica, Universidad Juárez del Estado de Durango, Durango, México.
Benito de Celis-AlonsoFacultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, México.
Kathryn A Wyman-ChickRegions Hospital/Health Partners Neuroscience Center, Saint Paul, MN, United States.
Oscar Arias-CarriónUnidad de Trastornos del Movimiento y Sueño/Centro de Innovación Médica Aplicada, Hospital General Dr. Manuel Gea González, Ciudad de México, México.
Universidad de Oviedo · ESBenemérita Universidad Autónoma de Puebla · MXHospital General Dr. Manuel Gea Gonzalez · MXRegions Hospital · USUniversidad Juárez del Estado de Durango · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The term scans without evidence of dopaminergic deficit (SWEDD) can be associated with any patient diagnosed at first with Parkinson's disease but with a negative dopamine transporter-single photon emission computed tomography (DaTSPECT), which does not confirm the presynaptic dopaminergic deficiency. Therefore, an alternative diagnosis should be sought to support parkinsonism as a clinical diagnosis. Parkinsonism is a well-known manifestation of frontotemporal lobar degeneration (FTLD), particularly frequent in those with positive DaTSPECT. Here, we reinforce previous observations that parkinsonism can be present in FTLD patients with negative DaTSPECT and therefore, FTLD may account for a percentage of patients with SWEDD. We gather the clinical observations supporting this hypothesis and describe a case report illustrating this idea. Studies suggest the result of DaTSPECT in FTLD may depend on the neuropathology and clinical subtype. However, most studies do not provide a clinical description of the clinical subtype or pathological features making the association between subtypes of FTLD and DaTSPECT results impossible at the moment. Further studies correlating clinical, neuropsychological, neuroimaging, genetic, and pathology findings are needed to better understand parkinsonism in FTLD.

Indexed as

dopamine transporter-singlefrontotemporal lobar degenerationparkinsonismphoton emission computed tomographypresynaptic dopaminergic deficiencyscans without evidence of dopaminergic deficit

Identifiers

PMID29881367
PMCPMC5976748
OpenAlexW2799371855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.